Cyclerion Therapeutics (CYCN) Other Gross PP&E Adjustments (2019 - 2025)
Cyclerion Therapeutics has reported Other Gross PP&E Adjustments over the past 7 years, most recently at -$23000.0 for Q3 2025.
- Quarterly results put Other Gross PP&E Adjustments at -$23000.0 for Q3 2025, up 83.21% from a year ago — trailing twelve months through Sep 2025 was -$23000.0 (up 83.21% YoY), and the annual figure for FY2024 was -$7.0 million, down 0.73%.
- Other Gross PP&E Adjustments for Q3 2025 was -$23000.0 at Cyclerion Therapeutics, up from -$80000.0 in the prior quarter.
- Over the last five years, Other Gross PP&E Adjustments for CYCN hit a ceiling of $909000.0 in Q1 2022 and a floor of -$40.7 million in Q1 2021.
- Median Other Gross PP&E Adjustments over the past 5 years was -$189000.0 (2024), compared with a mean of -$3.8 million.
- Biggest five-year swings in Other Gross PP&E Adjustments: soared 107.97% in 2022 and later plummeted 481.01% in 2024.
- Cyclerion Therapeutics' Other Gross PP&E Adjustments stood at -$6.8 million in 2021, then decreased by 8.07% to -$7.4 million in 2022, then rose by 6.03% to -$6.9 million in 2023, then decreased by 0.73% to -$7.0 million in 2024, then surged by 99.67% to -$23000.0 in 2025.
- The last three reported values for Other Gross PP&E Adjustments were -$23000.0 (Q3 2025), -$80000.0 (Q2 2025), and -$363000.0 (Q1 2025) per Business Quant data.